ImmunityBio shares fall on FDA warning letter over cancer therapy claims in ad

ImmunityBio shares fall on FDA warning letter over cancer therapy claims in ad | Reuters Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv The corporate logo of the U.S. Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed/File Photo Purchase Licensing Rights, opens new tab Companies ImmunityBio did not immediately respond to a Reuters request for comment. Immunitybio Inc Follow U.S. Foo ...